RTA-GLP3 (RETA)10mg

RTA-GLP3 is our lab-tested retatrutide, the investigational "triple-G" peptide known in research circles as reta. It acts on three metabolic receptors at once: GLP-1, GIP, and glucagon. That triple action has made retatrutide one of the most closely watched compounds in metabolic and weight research.

Research centers on how the GLP-1 arm curbs appetite and slows stomach emptying, the GIP arm supports insulin response and fat metabolism, and the glucagon arm raises energy expenditure and targets fat stored in the liver. Most studies focus on body weight, body composition, appetite, blood-sugar control, and liver fat. The added glucagon activity is what sets it apart from dual-agonist peptides.

Unlike most research peptides, retatrutide has been through large randomized human trials for obesity and type 2 diabetes, though it remains investigational and is not FDA-approved.